These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 15651756

  • 1. Health-related quality of life in HIV patients switching to twice-daily indinavir/ritonavir regimen or continuing with three-times-daily indinavir-based therapy.
    Badía X, Podzamczer D, Moral I, Roset M, Arnaiz JA, Loncà M, Casiró A, Rosón B, Gatell JM, BestQol Study Group.
    Antivir Ther; 2004 Dec; 9(6):979-85. PubMed ID: 15651756
    [Abstract] [Full Text] [Related]

  • 2. A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study).
    Burger DM, Aarnoutse RE, Dieleman JP, Gyssens IC, Nouwen J, de Marie S, Koopmans PP, Stek M, van der Ende ME.
    Antivir Ther; 2003 Oct; 8(5):455-61. PubMed ID: 14640393
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.
    Mootsikapun P, Chetchotisakd P, Anunnatsiri S, Boonyaprawit P.
    Antivir Ther; 2005 Oct; 10(8):911-6. PubMed ID: 16430196
    [Abstract] [Full Text] [Related]

  • 4. Indinavir/ritonavir-based therapy in HIV-1-infected antiretroviral therapy-naive patients: comparison of 800/100 mg and 400/100 mg twice daily.
    Konopnicki D, De Wit S, Poll B, Crommentuyn K, Huitema A, Clumeck N.
    HIV Med; 2005 Jan; 6(1):1-6. PubMed ID: 15670245
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lamivudine and indinavir/ritonavir maintenance therapy in highly pretreated HIV-infected patients (Vista ANRS 109).
    Launay O, Duval X, Dalban C, Descamps D, Peytavin G, Certain A, Mouajjah S, Ralaimazava P, Verdon R, Costagliola D, Clavel F, ANRS 109 VISTA Study Group.
    Antivir Ther; 2006 Jan; 11(7):889-99. PubMed ID: 17302251
    [Abstract] [Full Text] [Related]

  • 7. Using ritonavir with indinavir in cases of virologic failure.
    TreatmentUpdate; 2001 Jan; 12(12):7. PubMed ID: 11570095
    [No Abstract] [Full Text] [Related]

  • 8. Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).
    Boyd MA, Srasuebkul P, Khongphattanayothin M, Ruxrungtham K, Hassink EA, Duncombe CJ, Ubolyam S, Burger DM, Reiss P, Stek M, Lange J, Cooper DA, Phanuphak P.
    Antivir Ther; 2006 Jan; 11(2):223-32. PubMed ID: 16640103
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine.
    Coplan PM, Cook JR, Carides GW, Heyse JF, Wu AW, Hammer SM, Nguyen BY, Meibohm AR, DiNubile MJ, AIDS Clinical Trials Group 320 Study Team.
    Clin Infect Dis; 2004 Aug 01; 39(3):426-33. PubMed ID: 15307012
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trial.
    Spire B, Marcellin F, Cohen-Codar I, Flandre P, Boue F, Dellamonica P, Raffi F, Norton M, Van Philippe N, Delfraissy JF.
    Antivir Ther; 2008 Aug 01; 13(4):591-9. PubMed ID: 18672538
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals.
    Duvivier C, Myrto A, Marcelin AG, Ghosn J, Ait-Mohand H, Schneider L, Agher R, Bricaire F, Costagliola D, Calvez V, Peytavin G, Katlama C.
    Antivir Ther; 2003 Dec 01; 8(6):603-9. PubMed ID: 14760894
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Switch from ritonavir to indinavir in combination therapy for HIV-1-infected children.
    Pelton SI, Stanley K, Yogev R, Fletcher CV, McIntosh K, Wiznia A, Nachman S, Pediatric AIDS Clinical Trials Group 338 Study Team.
    Clin Infect Dis; 2005 Apr 15; 40(8):1181-7. PubMed ID: 15791520
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Simplifying drug regimens.
    HIV Hotline; 1998 Mar 15; 8(1):11. PubMed ID: 11365353
    [Abstract] [Full Text] [Related]

  • 20. The choice of HIV protease inhibitor: indinavir is currently the best option.
    Prescrire Int; 1999 Apr 15; 8(40):55-60. PubMed ID: 10848067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.